XML 59 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Operating Activities      
Net income $ 27,258 $ 23,813 $ 14,802
Adjustments to reconcile net income to net cash provided by operating activities:      
Provision for loan losses 9,850 17,800 35,250
Depreciation expense 5,440 5,074 5,276
Amortization of mortgage servicing rights 1,964 1,388 1,424
Valuation allowance on mortgage servicing rights 676 (45) (132)
Securities amortization, net 4,717 2,693 1,794
Amortization of purchased intangible assets 1,835 1,939 2,066
Earnings on cash surrender value of life insurance policies (1,206) (1,200) (1,246)
Gain on life insurance benefit   (141) (67)
Gain on sale of insurance related business line     (988)
Securities gains, net of impairment (1,367) (11,357) (2,979)
Gain on loans sold (7,068) (3,494) (5,152)
Loans originated for sale (246,596) (195,344) (274,111)
Proceeds from loan sales 253,259 188,063 278,546
Stock based compensation expense 491 173 114
Stock portion of director retainer fee expense 338 220  
Loss on sale and write-down of OREO 1,359 2,744 1,097
Prepayment penalty on FHLB advance 1,313    
Change in other assets and liabilities 1,928 3,734 6,940
Net cash provided by operating activities 54,191 36,060 62,634
Investing Activities      
Purchases of securities available for sale (220,543) (527,834) (363,844)
Proceeds from calls, maturities, and payments on securities available for sale 131,130 120,588 157,154
Proceeds from sales of securities available for sale 64,176 366,559 111,564
Loan originations and payments, net (15,060) 102,983 154,068
Purchases of premises and equipment (7,387) (6,865) (4,660)
Proceeds from sale of OREO 12,706 16,346 8,928
Sale of insurance related business line     2,000
Purchase of life insurance policies (10,000)    
Proceeds from redemption of restricted stock 217 3,646 7,857
Proceeds from life insurance benefit   893 124
Cash received from branch acquisitions, net 5,464    
Net cash provided (used) by investing activities (39,297) 76,316 73,191
Financing Activities      
Net change in deposits (11,709) (51,664) (59,086)
Net change in other borrowings 8,730 (7,392) (14,450)
Proceeds from FHLB advances 95,000 15,000  
Repayment of FHLB advances (106,688) (15,638) (70,200)
Cash dividends on preferred stock (1,967) (2,850) (2,850)
Cash dividends on common stock (1,623) (807) (805)
Repurchase of preferred shares (40,255)    
Proceeds from exercise of stock options 120    
Net cash (used) by financing activities (58,392) (63,351) (147,391)
Net change in cash and cash equivalents (43,498) 49,025 (11,566)
Cash and cash equivalents, beginning of year 109,148 60,123 71,689
Cash and cash equivalents, end of year 65,650 109,148 60,123
Supplemental cash flow information      
Interest paid 15,382 23,263 34,714
Income taxes paid/(refunded) 3,893 2,672 (1,675)
Supplemental non cash disclosure      
Loan balances transferred to foreclosed real estate $ 5,286 $ 23,093 $ 11,115